S. Kanzaki et al., EVIDENCE THAT HUMAN BONE-CELLS IN CULTURE PRODUCE INSULIN-LIKE GROWTHFACTOR-BINDING PROTEIN-4 AND PROTEIN-5 PROTEASES, Endocrinology, 134(1), 1994, pp. 383-392
Previous studies have shown that the actions of insulin-like growth fa
ctor-II (IGF-II) in bone are determined by both its concentration and
the concentrations of the IGF-binding proteins (IGFBPs). As IGFBP conc
entrations may be regulated not only at the level of production, but a
lso at the level of degradation, IGFBP proteases may be an important c
omponent of the IGF-II regulatory system. In this study, we have ident
ified IGFBP-4 and IGFBP-5 protease activity in the conditioned medium
(CM) of the human osteosarcoma U2 cell line (U20S) and untransformed n
ormal human bone cell (HBC) derived from skull. Proteolysis of the 29-
kilodalton (kDa) [I-125]IGFBP-5 produced an 18- to 20-kDa fragment of
IGFBP-5, and 25 kDa [I-125]IGFBP-4 yielded two lower mol wt fragments
in the presence of IGF-II. CM from IGF-II-treated U20S and normal HBC
cultures exhibited decreased IGFBP-5 proteolytic activity compared to
control cultures. In contrast, CM from IGF-II-treated HBC cultures had
increased proteolytic activity against IGFBP-4. To determine the mech
anisms by which IGF-II modulates IGFBP-4 and -5 proteolytic activity,
CM from control U20S cell culture was incubated with [I-125]IGFBP-4 or
-5 in the presence of Various concentrations of IGF-II and IGF analog
s under cell-free conditions. It was found that exogenous IGF-II stimu
lated IGFBP-4 proteolysis, but IGF analogs that had no or extremely lo
w affinity to IGFBP-4 failed to induce IGFBP-4 proteolysis. On the con
trary, exogenous IGF-II had no effect on IGFBP-5 proteolysis in cell-f
ree U20S CM. Both IGFBP-4 and IGFBP-5 proteolytic activities were inhi
bited by aprotinin, zinc chloride, and EDTA and eluted as a single maj
or peak between mol wt markers of 160 and 67 kDa upon gel filtration.
Based on the findings that HBCs in culture produce a protease(s) capab
le of cleaving both IGFBP-4 and IGFBP-5 and that IGF-II can promote or
inhibit proteolytic degradation of IGFBP-4 and IGFBP-5, respectively,
it is proposed that IGFBP protease(s) may be an important modulator o
f IGF activity in bone.